Polidocanol for endovenous microfoam sclerosant therapy

The American College of Phlebology 22nd Annual Congress: Marco Island, USA, 6–9 November 2008

(2009)   PHLEBOLOGY

Transient adverse events positively associated with patent foramen ovale after ultrasound-guided foam sclerotherapy

(2009) Pauline Raymond-Martimbeau   PHLEBOLOGY

The Lytic Effects of Detergent Sclerosants on Erythrocytes, Platelets, Endothelial Cells and Microparticles are Attenuated by Albumin and other Plasma Components in Vitro

(2008) K. Parsi et al.   EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY

Prospective randomized efficacy of ultrasound-guided foam sclerotherapy compared with ultrasound-guided liquid sclerotherapy in the treatment of symptomatic venous malformations

(2008) Takashi Yamaki et al.   JOURNAL OF VASCULAR SURGERY

Comparisons of side effects using air and carbon dioxide foam for endovenous chemical ablation

(2008) Nick Morrison et al.   JOURNAL OF VASCULAR SURGERY

More on Microembolism and Foam Sclerotherapy

(2008)   NEW ENGLAND JOURNAL OF MEDICINE

Microembolism during Foam Sclerotherapy of Varicose Veins

(2008) Roeland P.M. Ceulen et al.   NEW ENGLAND JOURNAL OF MEDICINE

Major neurological events following foam sclerotherapy

(2008) R G Bush et al.   PHLEBOLOGY

Duplex ultrasound and efficacy criteria in foam sclerotherapy from the 2ndEuropean Consensus Meeting on Foam Sclerotherapy 2006, Tegernsee, Germany

(2008) Breu et al.   Vasa-European Journal of Vascular Medicine

Efficacy and Safety of Great Saphenous Vein Sclerotherapy Using Standardised Polidocanol Foam (ESAF): A Randomised Controlled Multicentre Clinical Trial

(2007) E. Rabe et al.   EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY